Profile
Mr. Mark A. Wegter is a Managing Partner at LSP Advisory BV and a Partner at EQT Life Sciences Group BV.
He is on the Board of Directors at PamGene BV, PamGene International BV and LSP Advisory BV.
Mr. Wegter was previously employed as a Chairman-Supervisory Board by Kiadis Pharma BV, a Chairman-Supervisory Board by Kiadis Pharma NV, and a Director-Executive Board by 4-Antibody AG.
He also served on the board at European Biotech Acquisition Corp.
and VitrOmics Healthcare Holding BV.
He received his graduate degree from Erasmus University Rotterdam.
Mark Wegter active positions
| Companies | Position | Start |
|---|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Private Equity Investor | 1997-12-31 |
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products and clinical settings | Director/Board Member | 2000-11-30 |
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology Provides biotechnology products for pharma and medical research | Director/Board Member | 2009-10-13 |
LSP Advisory BV
LSP Advisory BV Investment ManagersFinance Provides investment advice | Chief Executive Officer | 1997-12-31 |
Former positions of Mark Wegter
| Companies | Position | End |
|---|---|---|
| EURO BIOT | Director/Board Member | 2023-02-27 |
VitrOmics Healthcare Holding BV
VitrOmics Healthcare Holding BV Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceutical manufacturing services | Director/Board Member | 2014-12-31 |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | 2010-12-31 |
| KIADIS PHARMA N.V. | Chairman | - |
Kiadis Pharma BV
Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Chairman | - |
Training of Mark Wegter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology Provides biotechnology products for pharma and medical research | Health Technology |
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products and clinical settings | Health Technology |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Erasmus University Rotterdam
Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiadis Pharma BV
Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Health Technology |
VitrOmics Healthcare Holding BV
VitrOmics Healthcare Holding BV Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceutical manufacturing services | Health Technology |
LSP Advisory BV
LSP Advisory BV Investment ManagersFinance Provides investment advice | Finance |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
European Biotech Acquisition Corp.
European Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Mark Wegter
















